Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions

Kyle LaHucik

Senior Reporter

Famed oncologist Sid Mukherjee and repeat biotech co-founder Lew Cantley have teamed up to form Faeth Therapeutics, a startup aiming to treat cancer the way …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

Pharma's wins and losses in Trump's sprawling executive order on drug prices

Sarepta loses CMO to RNA editing upstart; Another wave of personnel moves at Dyne

Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

US drugs rely heavily on ingredients made overseas, new report shows

Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes

New York-based partnership sets the standard for expanding clinical trial access for underserved and diverse ...

Sid Mukher­jee, Lew Cant­ley be­hind new can­cer biotech with food+drug com­bo treat­ment am­bi­tions

Senior Reporter

Sign up to read this article for free.

ImmunityBio, Inc.

Remote

Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions